Congenital Guillain-Barré syndrome associated with maternal inflammatory bowel disease is responsive to intravenous immunoglobulin

Eur J Paediatr Neurol. 2002;6(2):115-9. doi: 10.1053/ejpn.2002.0557.

Abstract

A 34-week floppy preterm infant born to a mother with acute ulcerative colitis presented with a progressive reduction in spontaneous limb movements, severe generalized hypotonia, areflexia, autonomic dysfunction and respiratory failure. Electromyography revealed pronounced denervation activity and markedly slow nerve conduction velocity (3 m/s) with evidence of conduction block. These findings indicated demyelination with additional axonal features. The infant was diagnosed with congenital Guillain-Barré syndrome, was treated with intravenous immunoglobulin and showed clinical improvement within 48 hours of treatment. The relationship between inflammatory bowel syndrome and inflammatory demyelinating polyneuropathy is discussed.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Colitis, Ulcerative / diagnosis*
  • Colitis, Ulcerative / drug therapy
  • Electromyography / drug effects
  • Female
  • Follow-Up Studies
  • Guillain-Barre Syndrome / congenital*
  • Guillain-Barre Syndrome / drug therapy
  • Humans
  • Immunization, Passive*
  • Infant
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy*
  • Male
  • Motor Neurons / drug effects
  • Motor Neurons / physiology
  • Muscle, Skeletal / innervation
  • Neurologic Examination / drug effects
  • Pregnancy
  • Pregnancy Complications / diagnosis*
  • Pregnancy Complications / drug therapy

Substances

  • Adrenal Cortex Hormones